Blood

Oncology & Cancer

Drug mechanism opens door for new anti-cancer immunotherapies

Researchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immune cell function, that could be exploited using new anti-cancer immunotherapies.

Oncology & Cancer

Closing in on a cure for common leukemia

A leukemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR)—meaning they are effectively cured of the disease.

page 3 from 40